WOLF Fundamental Analysis - GREY WOLF ANIMAL HEALTH CORP

Fundamental Rating

Taking everything into account, WOLF scores 3 out of 10 in our fundamental rating. WOLF was compared to 17 industry peers in the Consumer Staples Distribution & Retail industry. WOLF has an average financial health and profitability rating. WOLF does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year WOLF was profitable.

1.2 Ratios

With a decent Return On Assets value of 3.11%, WOLF is doing good in the industry, outperforming 64.71% of the companies in the same industry.

WOLF has a Return On Equity of 6.73%. This is in the lower half of the industry: WOLF underperforms 64.71% of its industry peers.

WOLF has a worse Return On Invested Capital (4.48%) than 64.71% of its industry peers.

		Industry Rank	Sector Rank
ROA	3.11%
ROE	6.73%
ROIC	4.48%

ROA(3y)3.02%

ROA(5y)N/A

ROE(3y)5.12%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 3.79%, WOLF belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.

WOLF has a better Operating Margin (9.58%) than 100.00% of its industry peers.

WOLF's Operating Margin has improved in the last couple of years.

WOLF has a better Gross Margin (52.52%) than 100.00% of its industry peers.

In the last couple of years the Gross Margin of WOLF has declined.

		Industry Rank	Sector Rank
OM	9.58%
PM (TTM)	3.79%
GM	52.52%

OM growth 3Y136.87%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.06%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WOLF is destroying value.

WOLF has more shares outstanding than it did 1 year ago.

The debt/assets ratio for WOLF is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 1.95 indicates that WOLF is not a great score, but indicates only limited risk for bankruptcy at the moment.

WOLF has a Altman-Z score of 1.95. This is comparable to the rest of the industry: WOLF outperforms 52.94% of its industry peers.

WOLF has a Debt/Equity ratio of 0.85. This is a neutral value indicating WOLF is somewhat dependend on debt financing.

With a decent Debt to Equity ratio value of 0.85, WOLF is doing good in the industry, outperforming 76.47% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.85
Debt/FCF	N/A
Altman-Z	1.95

ROIC/WACC0.76

WACC5.86%

2.3 Liquidity

WOLF has a Current Ratio of 2.47. This indicates that WOLF is financially healthy and has no problem in meeting its short term obligations.

WOLF's Current ratio of 2.47 is amongst the best of the industry. WOLF outperforms 94.12% of its industry peers.

A Quick Ratio of 1.56 indicates that WOLF should not have too much problems paying its short term obligations.

WOLF has a Quick ratio of 1.56. This is amongst the best in the industry. WOLF outperforms 94.12% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.47
Quick Ratio	1.56

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

WOLF shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.10%.

The Revenue has been growing slightly by 5.58% in the past year.

WOLF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.99% yearly.

EPS 1Y (TTM)5.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)5.58%

Revenue growth 3Y26.99%

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

WOLF is valuated rather expensively with a Price/Earnings ratio of 21.83.

WOLF's Price/Earnings ratio is in line with the industry average.

The average S&P500 Price/Earnings ratio is at 26.84. WOLF is around the same levels.

		Industry Rank	Sector Rank
PE	21.83
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WOLF is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	9.24

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

WOLF does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

GREY WOLF ANIMAL HEALTH CORP

TSX-V:WOLF (12/24/2025, 7:00:00 PM)

1.31

+0.01 (+0.77%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupConsumer Staples Distribution & Retail

GICS IndustryConsumer Staples Distribution & Retail

Earnings (Last)11-20 2025-11-20

Earnings (Next)04-15 2026-04-15

Inst Owners10.55%

Inst Owner ChangeN/A

Ins Owners13.08%

Ins Owner ChangeN/A

Market Cap44.79M

Revenue(TTM)53.61M

Net Income(TTM)2.03M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	21.83
Fwd PE	N/A
P/S	0.84
P/FCF	N/A
P/OCF	N/A
P/B	1.48
P/tB	N/A
EV/EBITDA	9.24

EPS(TTM)0.06

EY4.58%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS1.57

BVpS0.88

TBVpS-0.32

PEG (NY)N/A

PEG (5Y)N/A

Graham Number1.09

Profitability

		Industry Rank	Sector Rank
ROA	3.11%
ROE	6.73%
ROCE	8.75%
ROIC	4.48%
ROICexc	5.04%
ROICexgc	21.16%
OM	9.58%
PM (TTM)	3.79%
GM	52.52%
FCFM	N/A

ROA(3y)3.02%

ROA(5y)N/A

ROE(3y)5.12%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3Y125.9%

ROICexc growth 5YN/A

OM growth 3Y136.87%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.06%

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.82

Health

		Industry Rank	Sector Rank
Debt/Equity	0.85
Debt/FCF	N/A
Debt/EBITDA	3.84
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.47
Quick Ratio	1.56
Altman-Z	1.95

F-ScoreN/A

WACC5.86%

ROIC/WACC0.76

Cap/Depr(3y)19.25%

Cap/Depr(5y)N/A

Cap/Sales(3y)1.11%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)5.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)5.58%

Revenue growth 3Y26.99%

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y22.54%

EBIT growth 3Y200.8%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-43.58%

FCF growth 3Y-16.99%

FCF growth 5YN/A

OCF growth 1Y-28.24%

OCF growth 3Y-6.55%

OCF growth 5YN/A

GREY WOLF ANIMAL HEALTH CORP / WOLF.CA FAQ

What is the ChartMill fundamental rating of GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to WOLF.CA.

What is the valuation status of GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to GREY WOLF ANIMAL HEALTH CORP (WOLF.CA). This can be considered as Overvalued.

Can you provide the profitability details for GREY WOLF ANIMAL HEALTH CORP?

GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) has a profitability rating of 4 / 10.

What is the valuation of GREY WOLF ANIMAL HEALTH CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) is 21.83 and the Price/Book (PB) ratio is 1.48.

GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

GREY WOLF ANIMAL HEALTH CORP / WOLF.CA FAQ

What is the ChartMill fundamental rating of GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) stock?

What is the valuation status of GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) stock?

Can you provide the profitability details for GREY WOLF ANIMAL HEALTH CORP?

What is the valuation of GREY WOLF ANIMAL HEALTH CORP based on its PE and PB ratios?